Desmopressin
- TRADE NAMES: DDAVP (Sanofi-Aventis); Defirin; Desmospray; Minirin (Ferring); Minurin; Noctiva (Serenity); Octostim; Stimate (CSL Behring)
- INDICATIONS: Primary nocturnal enuresis; nocturia due to nocturnal polyuria (Noctiva)
- CLASS: Antidiuretic hormone analog
- HALF-LIFE: 75 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Citalopram, Demeclocycline, Hydromorphone, Meloxicam, Tapentadol
PREGNANCY CATEGORY: B
Noctiva: HYPONATREMIA
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric